Nama's AI scorecard currently rates Ensign Group Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is ENSG's P/E ratio?

Ensign Group trades at a trailing price-to-earnings ratio of 23.8.

When does ENSG report earnings?

Ensign Group's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $2.18.

What is the ENSG price target?

The median analyst price target from 5 analysts is $225.00, with a range of $210.00 – $240.00.

Is ENSG Shariah compliant?

Nama's AAOIFI-style screen reads Ensign Group as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does ENSG pay a dividend?

Yes — Ensign Group's dividend yield is 0.1%.

Nama Insights

Ensign Group (ENSG)

Healthcare · Medical Care Facilities · NASDAQ

Ensign Group (ENSG) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $10.56B, a trailing price-to-earnings ratio of 23.8 and a free-cash-flow yield of 3.5%. Over the most recent reported fiscal year, revenue grew 18.7% and free cash flow per share grew 94.1%. Nama's AI scorecard rates it Hold, 5.0 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Hold · 5.0/10

The sections balance. As of Nov 7, 2026.

Momentum

Lagging · -7.5% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-16.9%

How far the last close sits under the highest price of the past five years.

Market cap	$10.56B
Trailing P/E	23.8
Price / book	4.1
Price / sales	1.9
FCF yield	3.5%
Dividend yield	0.1%
Gross margin	16.6%
Operating margin	9.0%
Net margin	7.0%
Revenue growth (YoY)	+18.7%
Revenue growth (3-yr annual)	+18.7%
EPS growth (YoY)	+16.7%
FCF/share growth (YoY)	+94.1%
Beta	0.7
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Care Facilities

ENSG earnings

Next report: Feb 4, 2027 (Q4 2026, EPS estimate $2.18). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 27, 2026	$2.03	$1.97	+3.0%	$1.48B
Q2 2026	Jul 27, 2026	$1.92	$1.85	+3.8%	$1.44B
Q1 2026	Apr 30, 2026	$1.85	$1.82	+1.6%	$1.39B
Q4 2025	Feb 4, 2026	$1.82	$1.77	+2.8%	$1.36B

ENSG analyst price target

Median target $225.00 from 5 analysts, ranging $210.00 – $240.00.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
HCA	HCA Healthcare	$103.40B	16.5
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
FMS	Fresenius Medical Care	$12.15B	10.2
DVA	DaVita	$12.04B	13.6
UHS	Universal Health Services	$11.52B	8.6
PACS	PACS Group	$7.87B	20.1
CHE	Chemed	$6.84B	21.2

Explore live ENSG data on Nama Insights →

ENSG FAQ

Is ENSG a buy?: Nama's AI scorecard currently rates Ensign Group Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is ENSG's P/E ratio?: Ensign Group trades at a trailing price-to-earnings ratio of 23.8.
When does ENSG report earnings?: Ensign Group's next scheduled report is on Feb 4, 2027. Analysts expect EPS of $2.18.
What is the ENSG price target?: The median analyst price target from 5 analysts is $225.00, with a range of $210.00 – $240.00.
Is ENSG Shariah compliant?: Nama's AAOIFI-style screen reads Ensign Group as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does ENSG pay a dividend?: Yes — Ensign Group's dividend yield is 0.1%.